Community pharmacists and their teams are being encouraged to support the nation’s fight against COVID-19 by signposting patients with suspected or even confirmed SARS-COV-2 infection to the PRINCIPLE trial. The PRINCIPLE trial platform is a UK-wide priority trial to find treatments for COVID-19 and the only one based in primary care. It is designed to...
Department of Health and Social Care (DHSC) has today granted the following list of price concessions: Drug Pack Size Price Concession Ciprofloxacin 250mg tablets 10 £1.37 Hydrocortisone 2.5% cream 15g £44.00 Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets 28 £14.31 Lamotrigine 50mg tablets 56 £3.31 Rasagiline 1mg tablets 28 £10.07 Tamoxifen 20mg tablets 30 £13.99 Zonisamide...
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 14 Issue 2 September 2020) has been published and includes articles on: 5-fluorouracil (intravenous), capecitabine, tegafur: DPD testing recommended before initiation to identify patients at increased risk of severe and fatal toxicity Flucytosine (Ancotil): new contraindication in patients with DPD deficiency Niraparib...
Department of Health and Social Care (DHSC) has today issued a medicine supply notification for Fluoxetine 30mg capsules (Advanz) Advanz, the sole supplier, are out of stock of fluoxetine 30mg capsules with resupply expected mid-December 2020 Fluoxetine 10mg and 20mg capsules remain available A Serious Shortage Protocol (SSP) was issued on 20/10/2020 further details can...
Department of Health and Social Care (DHSC) has today issued a medicine supply notification for Salazopyrin En-Tabs (sulfasalazine) 500mg tablets Pfizer are out of stock of Salazopyrin En-Tabs until early December 2020 Generic versions of sulfasalazine 500mg gastro-resistant tablets remain available UKMI have advised there are no known differences in bioavailability between the branded and...
Recent Comments